Project DEAL

Global Biomarker Partnering: Updated Deal Trends, Players and Financials 2010-2021 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 8, 2021

The Global Biomarker Partnering Terms and Agreements 2010-2021: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies.

Key Points: 
  • The Global Biomarker Partnering Terms and Agreements 2010-2021: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies.
  • The report takes readers through the comprehensive biomarker deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering biomarker partnering deals.
  • Global Biomarker Partnering Terms and Agreements 2010-2021: Deal trends, players and financials provide the reader with the following key benefits:
    Insight into the terms included in a biomarker agreement, together with real-world clause examples
    Global Biomarker Partnering Terms and Agreements 2010-2021: Deal trends, players and financials is intended to provide the reader with an in-depth understanding and access to biomarker trends and structure of deals entered into by leading companies worldwide.
  • Biomarker Partnering Terms and Agreements includes:
    In Global Biomarker Partnering Terms and Agreements 2010-2021: Deal trends, players and financials, the available contracts are listed by:
    Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Global Proteomics Partnering Terms and Agreements Analysis Report 2020

Retrieved on: 
Monday, February 15, 2021

DUBLIN, Feb. 15, 2021 /PRNewswire/ -- The "Global Proteomics Partnering Terms and Agreements 2010 to 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 15, 2021 /PRNewswire/ -- The "Global Proteomics Partnering Terms and Agreements 2010 to 2020" report has been added to ResearchAndMarkets.com's offering.
  • The Global Proteomics Partnering Terms and Agreements 2010 to 2020 report provides an understanding and access to the Proteomics partnering deals and agreements entered into by the worlds leading healthcare companies.
  • The report provides a detailed understanding and analysis of how and why companies enter Proteomics partnering deals.
  • Global Proteomics Partnering Terms and Agreements 2010 to 2020 includes:
    In Global Proteomics Partnering Terms and Agreements 2010 to 2020, the available contracts are listed by:
    Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Global Proteomics Partnering Terms and Agreements Report 2020 with Updated Directory of 500+ Deal Records - ResearchAndMarkets.com

Retrieved on: 
Friday, February 12, 2021

The "Global Proteomics Partnering Terms and Agreements 2010 to 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Proteomics Partnering Terms and Agreements 2010 to 2020" report has been added to ResearchAndMarkets.com's offering.
  • The Global Proteomics Partnering Terms and Agreements 2010 to 2020 report provides an understanding and access to the Proteomics partnering deals and agreements entered into by the worlds leading healthcare companies.
  • The report provides a detailed understanding and analysis of how and why companies enter Proteomics partnering deals.
  • Global Proteomics Partnering Terms and Agreements 2010 to 2020 includes:
    In Global Proteomics Partnering Terms and Agreements 2010 to 2020, the available contracts are listed by:
    Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Royal Danish Library and Elsevier agree to four-year contract for reading and open access publishing

Retrieved on: 
Tuesday, January 26, 2021

AMSTERDAM, Jan. 26, 2021 /PRNewswire/ -- Elsevier , a global leader in research publishing and information analytics and the Royal Danish Library have agreed on a four-year contract to support continued reading and open access (OA) publishing for Danish researchers.

Key Points: 
  • AMSTERDAM, Jan. 26, 2021 /PRNewswire/ -- Elsevier , a global leader in research publishing and information analytics and the Royal Danish Library have agreed on a four-year contract to support continued reading and open access (OA) publishing for Danish researchers.
  • This is the first time the Danish consortium led by the Royal Danish Library has signed an open access transformative agreement with any publisher and this agreement complements Elsevier's transformative agreements across many European countries.
  • Elsevier will support the Danish researcher community's ambitions by enabling Danish researchers to publish open access across a broad range of Elsevier journals, therefore making their latest research freely available at the point of publication.
  • Gino Ussi, Executive Vice President, Elsevier said: "It's a real honourto be the first publisher to agree on a transformative contract to support Danish researchers.

The Royal Danish Library and Elsevier agree to four-year contract for reading and open access publishing

Retrieved on: 
Tuesday, January 26, 2021

AMSTERDAM, Jan. 26, 2021 /PRNewswire/ -- Elsevier , a global leader in research publishing and information analytics and the Royal Danish Library have agreed on a four-year contract to support continued reading and open access (OA) publishing for Danish researchers.

Key Points: 
  • AMSTERDAM, Jan. 26, 2021 /PRNewswire/ -- Elsevier , a global leader in research publishing and information analytics and the Royal Danish Library have agreed on a four-year contract to support continued reading and open access (OA) publishing for Danish researchers.
  • This is the first time the Danish consortium led by the Royal Danish Library has signed an open access transformative agreement with any publisher and this agreement complements Elsevier's transformative agreements across many European countries.
  • Elsevier will support the Danish researcher community's ambitions by enabling Danish researchers to publish open access across a broad range of Elsevier journals, therefore making their latest research freely available at the point of publication.
  • Gino Ussi, Executive Vice President, Elsevier said: "It's a real honourto be the first publisher to agree on a transformative contract to support Danish researchers.

Wiley Launches Flagship Interdisciplinary Open Access Journal Natural Sciences

Retrieved on: 
Tuesday, October 13, 2020

John Wiley and Sons Inc. (NYSE:JWA) (NYSE:JWB) today announced the launch of its new premier open access journal, Natural Sciences .

Key Points: 
  • John Wiley and Sons Inc. (NYSE:JWA) (NYSE:JWB) today announced the launch of its new premier open access journal, Natural Sciences .
  • The journal, which fully embraces open research principles, is one of the mutual initiatives agreed to by Projekt DEAL and Wiley.
  • We are pleased to celebrate another DEAL milestone with the launch of Natural Sciencesa fully open research, interdisciplinary journal that broadens Wileys open access portfolio of 170 fully open access journals and more than 1,400 hybrid journals.
  • Natural Sciences embraces innovative open research principles, including open and transparent peer review and decision-making processes, that accelerate the pace of discovery and make scientific research results easily accessible to all.

Global Biosimilars Partnering Terms and Agreements Report 2010-2020: Access to Over 140 Biosimilars Deal Records

Retrieved on: 
Thursday, September 24, 2020

DUBLIN, Sept. 24, 2020 /PRNewswire/ -- The "Global Biosimilars Partnering Terms and Agreements 2010 to 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Sept. 24, 2020 /PRNewswire/ -- The "Global Biosimilars Partnering Terms and Agreements 2010 to 2020" report has been added to ResearchAndMarkets.com's offering.
  • The Global Biosimilars Partnering Terms and Agreements 2010 to 2020 report provides an understanding and access to the Biosimilars partnering deals and agreements entered into by the worlds leading healthcare companies.
  • The report provides a detailed understanding and analysis of how and why companies enter Biosimilars partnering deals.
  • Global Biosimilars Partnering Terms and Agreements 2010 to 2020 includes:
    In Global Biosimilars Partnering Terms and Agreements 2010 to 2020, the available contracts are listed by:

Global Antibody Partnering Deals Collection 2014-2020 - Access to 1,300+ Online Deal Records; Headline, Upfront, Milestone and Royalty Data

Retrieved on: 
Friday, July 10, 2020

Chapter 2 provides an overview of the trends in Antibody dealmaking since 2014, including details of average headline, upfront, milestone and royalty terms.

Key Points: 
  • Chapter 2 provides an overview of the trends in Antibody dealmaking since 2014, including details of average headline, upfront, milestone and royalty terms.
  • Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
  • Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.
  • Chapter 7 provides a comprehensive and detailed review of Antibody partnering deals signed and announced since Jan to 2014.

Elsevier and the University of Florida Sign Pilot Agreement to Support Open Access Publishing and Research

Retrieved on: 
Wednesday, July 1, 2020

The agreement will support UF's open access goals by providing the university's researchers with incentives to publish OA articles.

Key Points: 
  • The agreement will support UF's open access goals by providing the university's researchers with incentives to publish OA articles.
  • The pilot agreement is an amendment to the existing licensing agreement UF currently has with Elsevier.
  • "I sought a transformative agreement that would benefit UF authors choosing to publish open access articles in Elsevier journals, and Elsevier listened!
  • The agreement provides a discount for corresponding authors publishing open access articles in most Elsevier open access and hybrid journals.

Elsevier and the University of Florida Sign Pilot Agreement to Support Open Access Publishing and Research

Retrieved on: 
Wednesday, July 1, 2020

The agreement will support UF's open access goals by providing the university's researchers with incentives to publish OA articles.

Key Points: 
  • The agreement will support UF's open access goals by providing the university's researchers with incentives to publish OA articles.
  • The pilot agreement is an amendment to the existing licensing agreement UF currently has with Elsevier.
  • "I sought a transformative agreement that would benefit UF authors choosing to publish open access articles in Elsevier journals, and Elsevier listened!
  • The agreement provides a discount for corresponding authors publishing open access articles in most Elsevier open access and hybrid journals.